Skip to main content

Find Clinical Trials

Home
Conditions
Hypercholesterolemia

Clinical trial condition

Hypercholesterolemia

Explore clinical trials studying Hypercholesterolemia. Study availability and eligibility vary by location and protocol.

719 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Hypercholesterolemia trial results

Completed

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)

NCT00276484

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

NCT00418834

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

NCT00783263

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)

NCT00276458

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Study to Evaluate Fasting/Postprandial Serum Apolipoprotein B-48 (ApoB-48) Levels in Diabetic Participants With Normal to Moderately High Low Density Lipoprotein-C (LDL-C) Levels (MK-0653A-259 AM1)

NCT01333436

Conditions: Dyslipidemia, Dyslipidemias, Hypercholesterolemia, +4 more
Locations: MSD Korea Ltd. Seoul, South Korea

View Trial Details

Completed

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

NCT03867110

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia

NCT04784442

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Tokyo-Eki Center-Building Clinic Chuo-ku,Tokyo, Japan

View Trial Details

Completed

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

NCT03882892

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

NCT00395473

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details

Completed

MK0653A (Ezetimibe (+) Simvastatin) Compared to an Approved Drug (Atorvastatin) for the Treatment of High Cholesterol (0653A-051)(COMPLETED)

NCT00092690

Conditions: Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations: Not specified

View Trial Details